BRUKER DALTONICS OBTAINS S. KOREAN REGISTRATION OF AUTOFLEX II MALDI-TOF MASS SPECTROMETER

Bruker Daltonics Inc. today announces that it has obtained registration of its leading autoflex(R) II MALDI-TOF mass spectrometers as Class I Medical Devices with the Korea Food and Drug Administration. MALDI-TOF mass spectrometry is increasingly being applied to the areas of clinical proteomics, functional genomics and biomarker discovery as a clinical research tool. With recent advances, usage of MALDI-TOF in in-vitro diagnostics (IVD) applications has become very promising. Bruker Daltonics has now taken the important step of registering its autoflex II systems as medical devices in the Republic of Korea, to facilitate regulatory approval of novel mass-spectrometry based IVD methods by its Korean customers.

MENAFN (http://menafn.com/qn_news_story.asp?StoryId=CqVL7WbKbmJiYyJm4mJK)